Abstract
To the Editor: Primary Merkel cell carcinoma (MCC) has a 25% to 30% risk of occult nodal metastasis,1 and the National Comprehensive Cancer Network (NCCN) guidelines recommend sentinel lymph node biopsy (SLNB) in all patients without clinical nodal disease or known metastasis.2 SLNB status guides the prognosis and indications for adjuvant therapy.1 The rates of SLNB compliance have not been studied for MCC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
